Ochiai Yuko, Ochiai Haruyuki
Shin-Nagata Eye Institute, Kobe-shi Japan.
Jpn J Ophthalmol. 2002 May-Jun;46(3):249-53. doi: 10.1016/s0021-5155(01)00523-8.
Diabetic retinopathy and glaucoma are the primary causes of acquired blindness. Cytokines including transforming growth factor (TGF)-beta may be involved in these diseases. We therefore collected aqueous humor samples from patients with glaucoma and/or diabetes who were undergoing surgery, and determined the concentration of TGF-beta.
Aqueous humor samples were collected from 80 patients (84 eyes), including 19 eyes with primary open-angle glaucoma (POAG), 22 eyes with diabetes, and 18 eyes with diabetes complicated with POAG. Twenty-five eyes with cataract served as controls. The concentration of TGF-beta1 or TGF-beta2 was measured by enzyme-linked immunosorbent assay.
The concentration of TGF-beta1 was less than 0.1 pg/mL in all of the groups. In contrast to controls who had 1001.4 +/- 444.1 pg/mL, the concentration of total TGF-beta2 in the diabetes group was 1715.6 +/- 882.1 pg/mL, and that in the diabetes complicated with POAG group was 1692.9 +/- 361.9 pg/mL. These were significantly higher than that in controls. In contrast to the controls who had 321.2 +/- 197.9 pg/mL, the concentration of mature TGF-beta2 with POAG was 822.5 +/- 484.4 pg/mL, and that of diabetes complicated with POAG was 1058.9 +/- 648.4 pg/mL. These were significantly higher than that in the controls. The eyes with diabetes complicated with POAG also had a significantly higher concentration than the eyes with diabetes alone.
Total TGF-beta2 and mature TGF-beta2 in high concentration may correlate with progression of POAG, diabetes, and diabetes complicated with POAG.
糖尿病视网膜病变和青光眼是后天性失明的主要原因。包括转化生长因子(TGF)-β在内的细胞因子可能与这些疾病有关。因此,我们收集了接受手术的青光眼和/或糖尿病患者的房水样本,并测定了TGF-β的浓度。
收集了80例患者(84只眼)的房水样本,其中包括19只原发性开角型青光眼(POAG)眼、22只糖尿病眼和18只糖尿病合并POAG眼。25只白内障眼作为对照。采用酶联免疫吸附测定法测量TGF-β1或TGF-β2的浓度。
所有组中TGF-β1的浓度均低于0.1 pg/mL。与对照组(1001.4±444.1 pg/mL)相比,糖尿病组总TGF-β2的浓度为1715.6±882.1 pg/mL,糖尿病合并POAG组为1692.9±361.9 pg/mL。这些浓度显著高于对照组。与对照组(321.2±197.9 pg/mL)相比,POAG组成熟TGF-β2的浓度为822.5±484.4 pg/mL,糖尿病合并POAG组为1058.9±648.4 pg/mL。这些浓度显著高于对照组。糖尿病合并POAG的眼睛的浓度也显著高于单纯糖尿病的眼睛。
高浓度的总TGF-β2和成熟TGF-β2可能与POAG、糖尿病以及糖尿病合并POAG的进展相关。